Skip to main content
. 2022 Sep 16;12:15619. doi: 10.1038/s41598-022-19887-x

Table 1.

Characteristics of patients exhibiting lung toxicities related to bevacizumab.

Variable Value (%)
Number of patients 1679
Sex
Male 1071 (63.8)
Female 546 (32.5)
Unknown 62 (3.7)
Age
10s 2 (0.1)
20s 1 (0.1)
30s 22 (1.3)
40s 84 (5.0)
50s 222 (13.2)
60s 585 (34.8)
70s 565 (33.7)
80s 94 (5.6)
90s 1 (0.1)
Unknown 103 (6.1)